How to Treat Hair Loss Due to Inflammation: What Works

Treating hair loss caused by inflammation depends entirely on what kind of inflammation is involved, because the treatments that work for one type can be useless or even harmful for another. Inflammatory hair loss spans a wide range of conditions, from autoimmune attacks that cause patchy bald spots to slow-burning scarring processes that permanently destroy follicles. Some forms respond well to targeted medications like JAK inhibitors, while others require aggressive early intervention with steroids or antimalarials to prevent irreversible damage. The gap between “treatable” and “too late” is often narrower than people expect, which makes understanding the landscape genuinely important.

How Inflammation Damages Hair Follicles

Hair follicles normally enjoy a kind of immunological invisibility. They exist in a state where the immune system largely leaves them alone, even though they cycle through growth and rest phases that involve rapid cell division. When that protection breaks down, immune cells flood in and attack the follicle from different angles depending on the condition. In alopecia areata, immune cells swarm around the bulb at the base of the follicle, forcing it out of its growth phase prematurely.¹ In scarring conditions like lichen planopilaris, the immune attack targets the upper part of the follicle where stem cells live, and once those stem cells are destroyed, the follicle cannot regenerate.²

Stress appears to play a role in triggering this immune collapse, though the exact mechanisms are still being mapped. Research has focused on how neurogenic stress signals can disrupt the follicle’s immune-protected status, essentially sending a “look here” signal to immune cells that would otherwise ignore the follicle.³ This helps explain why inflammatory hair loss often flares during periods of physical or emotional stress, though stress alone is rarely the whole story.

Scarring Versus Non-Scarring Conditions

The single most important distinction in inflammatory hair loss is whether the condition scars. Non-scarring inflammatory conditions, like alopecia areata, damage follicles temporarily. The follicle survives and can potentially regrow hair once the inflammation is controlled. Scarring (cicatricial) conditions permanently replace the follicle with scar tissue. Once that happens in a given area, no treatment will bring back hair there. The urgency of treatment is completely different between these two categories.

Scarring alopecias include lichen planopilaris and its variant frontal fibrosing alopecia, central centrifugal cicatricial alopecia, and folliculitis decalvans. Each involves a different inflammatory profile. Lichen planopilaris and frontal fibrosing alopecia share similar tissue findings, with immune cells clustering around the upper follicle in a distinctive pattern.⁴ Folliculitis decalvans involves a different immune cell type and is linked to bacterial infection alongside immune dysfunction, with Staphylococcus aureus frequently found in affected areas.⁵ Central centrifugal cicatricial alopecia occurs overwhelmingly in Black women and involves genetic factors including mutations that affect proteins responsible for proper follicle development, along with a predisposition toward fibrotic tissue responses.⁶

Knowing which type you are dealing with shapes every treatment decision that follows. A treatment that calms immune activity might preserve remaining follicles in lichen planopilaris, but a person with folliculitis decalvans might also need antibiotics targeted at the bacterial component. This is why self-diagnosing inflammatory hair loss and treating it on your own is genuinely risky.

Getting an Accurate Diagnosis

A dermatologist experienced in hair disorders will typically start with dermoscopy, which is essentially a magnified examination of the scalp surface. Different conditions leave characteristic calling cards visible under magnification. Lichen planopilaris shows concentric white scales around follicle openings. Folliculitis decalvans produces distinctive hair tufts where multiple hairs emerge from a single opening. Central centrifugal cicatricial alopecia shows a grey-white halo around hairs. Discoid lupus, another inflammatory cause, displays red dots or keratotic plugs.⁷

When dermoscopy alone is not conclusive, a scalp biopsy provides a definitive answer. For scarring alopecias in particular, the biopsy site is often chosen based on what dermoscopy shows, targeting the most active edges of the affected area. Artificial intelligence tools are also emerging as diagnostic aids. One deep-learning system analyzing trichoscopy images achieved about 89% overall accuracy in identifying alopecia areata and assessing disease activity.⁸ These tools are not replacing dermatologists yet, but they point toward faster screening in the future.

Steroids and Hydroxychloroquine for Scarring Alopecias

For most scarring inflammatory alopecias, the treatment goal is not regrowth but stopping progression. The follicles already lost to scarring are gone. Treatment aims to save the remaining ones. The European Academy of Dermatology and Venereology positions potent topical steroids and steroid injections directly into the scalp as first-line therapies for lichen planopilaris, either alone or combined with other treatments.⁹ Intralesional steroid injections deliver medication directly to the inflamed tissue and are typically repeated every four to six weeks during active disease.

When steroids alone are not enough, hydroxychloroquine is one of the most commonly used systemic options for lichen planopilaris. In a retrospective review, about 61% of patients achieved a complete response to hydroxychloroquine, with an additional 9% showing partial improvement.¹⁰ Those are encouraging numbers for a condition that can be stubbornly difficult to manage, though “complete response” in the context of scarring alopecia means the disease has stopped progressing, not that lost hair has returned.

For central centrifugal cicatricial alopecia, treatment also involves addressing potential triggers. Traction hairstyles and chemical relaxers may serve as the initial insult that sets off the inflammatory cascade in genetically predisposed individuals.⁶ Eliminating these triggers while using anti-inflammatory treatments gives remaining follicles the best chance of survival. Folliculitis decalvans, being partly driven by bacterial infection, often requires prolonged courses of antibiotics alongside anti-inflammatory approaches.

JAK Inhibitors for Alopecia Areata

Alopecia areata has been historically frustrating to treat. Steroids help some people, but many severe cases are resistant. The landscape shifted dramatically with the arrival of Janus kinase inhibitors, which block the signaling pathways that immune cells use to coordinate their attack on the hair follicle. Three JAK inhibitors now have FDA approval specifically for alopecia areata: baricitinib, ritlecitinib, and deuruxolitinib.¹¹

The clinical trial results give a realistic picture of what to expect. In pivotal trials, roughly 35 to 40% of patients on baricitinib achieved meaningful regrowth (defined as 80% or more scalp coverage) by 36 weeks. Ritlecitinib got about 23% of patients to that level by week 24, and deuruxolitinib about 31% at 24 weeks.¹¹ Real-world data has been broadly consistent: one study found about 42% of baricitinib patients and roughly 42% of ritlecitinib patients achieved that level of regrowth at 36 weeks, with most side effects being mild.¹²

A reality check is warranted here. These drugs work well for a meaningful percentage of patients, but they are not cures. Alopecia areata commonly relapses when treatment is stopped or the dose is reduced. Shorter disease duration before starting treatment appears to predict better outcomes. Patients who have been losing hair for many years may respond less robustly. The drugs also come with monitoring requirements and potential side effects common to immune-modifying medications, so the decision to start them involves weighing the severity of hair loss against the commitment and risks of ongoing treatment.

The Hidden Inflammatory Component of Pattern Hair Loss

You might not think of common male or female pattern hair loss as an inflammatory condition, but growing evidence suggests that low-grade inflammation plays a more significant role than previously appreciated. The miniaturization of hair follicles in pattern hair loss is frequently accompanied by inflammation and increased oil production, creating an environment that supports pro-inflammatory microorganisms on the scalp.¹³

A comparative study found perifollicular inflammation and fibrosis in the clinically normal-appearing scalp of about 81% of pattern hair loss patients, particularly those over 44, with more advanced hair loss, or who had previously responded poorly to standard treatments. When researchers treated these patients with anti-inflammatory agents alongside the usual hormone-blocking therapies, roughly 67% showed greater improvement than they had with standard treatment alone.¹⁴ The anti-inflammatory additions included tetracycline antibiotics, topical calcineurin inhibitors, and plant-derived compounds. This suggests that for a substantial number of people with pattern hair loss, addressing inflammation alongside hormonal factors may produce better results than hormonal treatment alone.

This is where the research gets genuinely interesting, because it points toward a spectrum rather than a clean divide between “inflammatory” and “hormonal” hair loss. Some researchers have proposed that pattern hair loss and certain scarring alopecias may exist on a continuum, where chronic low-grade inflammation around the follicle gradually edges toward fibrosis over years.¹⁴ If that model holds up, it would explain why some pattern hair loss patients stop responding to finasteride or minoxidil alone.

Antifungal Shampoos and the Scalp Microbiome

One of the more accessible anti-inflammatory interventions is antifungal shampoo, particularly ketoconazole. The Malassezia yeast that naturally lives on the scalp can drive inflammatory responses, and reducing its population appears to benefit hair retention. Research comparing ketoconazole shampoo use in people with pattern hair loss suggested a meaningful effect on the course of the condition, pointing to Malassezia as a contributor to the inflammatory reaction around follicles.¹⁵

Ketoconazole shampoo is widely available over the counter in 1% strength and by prescription at 2%. It is generally used two to three times per week, left on the scalp for several minutes before rinsing. For people whose hair loss involves scalp redness, flaking, or itching alongside thinning, adding an antifungal shampoo to the routine is low-risk and may address a piece of the inflammatory puzzle that other treatments miss. It is not a standalone treatment for significant hair loss, but as part of a combination approach, it fills a gap that pure hormonal therapies do not touch.

Platelet-Rich Plasma and Emerging Regenerative Therapies

Platelet-rich plasma injections have gained popularity as a treatment for inflammatory hair loss, and the biological rationale is sound even if the clinical evidence is still catching up. When activated platelets are injected into the scalp, they release growth factors that promote blood vessel formation and cell growth, while also reducing pro-inflammatory signaling and oxidative stress in the local environment.¹⁶ The treatment essentially tries to shift the follicle’s neighborhood from a hostile, inflamed state to one that supports hair growth.

An emerging branch of this field involves extracellular vesicles, including exosomes derived from various stem cell sources. These tiny particles carry molecular signals that can activate hair growth pathways while suppressing inflammatory and hormonal signaling around the follicle.¹⁷ The research is still early stage, but the interest is high because these approaches target multiple pathways simultaneously rather than addressing just one aspect of the problem. For now, PRP remains the more established option, though protocols vary widely between clinics, making it hard to compare results across providers.

Low-Level Laser Therapy

Low-level laser therapy, also called photobiomodulation, uses specific wavelengths of red or near-infrared light to stimulate cellular activity in the scalp. In one study, after 24 weeks of treatment, hair density and hair thickness both increased significantly, while excess oil production on the scalp decreased.¹⁸ The reduction in oil production is relevant to the inflammatory picture, since excess sebum supports the microbial overgrowth that fuels scalp inflammation.

Low-level laser devices come in various forms, including helmets, caps, and combs, with a wide range of prices and quality. The treatment is non-invasive and has essentially no significant side effects, which makes it appealing as an add-on therapy. The effects are modest compared to pharmaceutical treatments, and the evidence base, while growing, consists mostly of small studies. For someone who is already using medical treatments and wants to add something with a reasonable safety profile, laser therapy is worth considering. As a sole treatment for active inflammatory hair loss, it is unlikely to be sufficient.

Nutritional Factors and Oxidative Stress

Diet and nutrient status influence the inflammatory environment around hair follicles in ways that are sometimes overlooked. Oxidative stress is a major driver of several hair-loss mechanisms, including the release of inflammatory signals that push follicles out of their growth phase. Nutrients that counter oxidative stress can support cellular repair and help maintain conditions favorable for hair growth.¹⁹

However, there is an important wrinkle that supplement marketing tends to ignore: higher doses of antioxidant nutrients do not necessarily work better. At excessive doses, some antioxidants can reverse course and actually become pro-oxidant, potentially worsening the problem they were meant to solve.¹⁹ This means that piling on high-dose supplements without addressing actual deficiencies can backfire. If blood work shows deficiencies in iron, vitamin D, zinc, or B vitamins, correcting those deficiencies is a reasonable part of a comprehensive approach. Megadosing on supplements without evidence of a deficiency is not.

An anti-inflammatory dietary pattern, rich in vegetables, fatty fish, nuts, and whole grains while low in processed foods and refined sugars, aligns with what we know about systemic inflammation and its downstream effects. No diet alone will reverse an active autoimmune attack on your hair follicles, but chronically elevated systemic inflammation from a poor diet is unlikely to help the situation either. Think of nutrition as the background conditions you can control while medical treatments handle the foreground.

When Treatments Need to Be Combined

One theme running through the research on inflammatory hair loss is that single-agent therapy often underperforms combination approaches. The study on pattern hair loss patients with hidden inflammation found that adding anti-inflammatory agents to standard hormonal therapy outperformed hormonal therapy alone in the majority of cases.¹⁴ For lichen planopilaris, steroid injections are often combined with oral medications like hydroxychloroquine.⁹ Even JAK inhibitors, as effective as they can be for alopecia areata, are sometimes used alongside topical treatments for better coverage.

The practical implication is that if you have been using one treatment with disappointing results, the answer may not be switching to a different single treatment but rather layering therapies that target different parts of the inflammatory process. A dermatologist who specializes in hair disorders can put together a regimen that addresses the hormonal, inflammatory, microbial, and nutritional dimensions simultaneously. The people who tend to do worst are those who bounce between single treatments for years without addressing the full scope of what is happening on their scalp. The evidence increasingly supports thinking about inflammatory hair loss as a multi-pathway problem that benefits from a multi-pathway response.

1
PubMed Central. Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM-1 Upregulation
2
PubMed. Upregulation of caveolae-associated structural proteins in the hair follicle bulge of lichen planopilaris and frontal fibrosing alopecia
3
PubMed Central. Immune Privilege Collapse and Alopecia Development: Is Stress a Factor
4
PubMed Central. Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features
5
PubMed Central. Folliculitis Decalvans: An Uncommon Case Report with Review of Literature
6
PubMed Central. Risk factors and comorbidities associated with central centrifugal cicatricial alopecia
7
PubMed. Dermoscopy guided scalp biopsy in cicatricial alopecia
8
PubMed Central. Analysis of trichoscopic images using deep neural networks for the diagnosis and activity assessment of alopecia areata – a retrospective study
9
PubMed Central. Management of classic lichen planopilaris: The EADV task force on hair diseases position statement
10
PubMed. The role of hydroxychloroquine in the treatment of lichen planopilaris: A retrospective case series and review
11
PubMed Central. Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
12
PubMed Central. Real-World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction
13
PubMed Central. Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment
14
Clinical, Cosmetic and Investigational Dermatology. Perifollicular Inflammation and Fibrosis in Androgenetic Alopecia: Implications for Diagnosis and Treatment – A Comparative Histopathologic and Clinical Study with Normal-Appearing Scalp
15
PubMed. Ketoconazole shampoo: effect of long-term use in androgenic alopecia
16
PubMed Central. Adjunctive regenerative therapies in hair transplantation: a comprehensive review of platelet-rich plasma, exosomes, and emerging methods
17
PubMed Central. Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects
18
PubMed Central. Assessment of Effects of Low-Level Light Therapy on Scalp Condition and Hair Growth
19
PubMed Central. Influence of Nutrition, Food Supplements and Lifestyle in Hair Disorders